Accura advised Nordic Capital, while Plesner has advised the LEO Foundation and LEO Pharma in connection with the investment. The private equity investor Nordic Capital invested EUR...
Nordic Capital’s €450 Million Investment in Leo Pharma
NIL Technology’s DKK 200 Million Investment Round
Accura advised EIC Fund in connection with its investment. The Danish nanotechnology company NIL Technology has secured DKK 200m in connection with an investment round. One...
Orkla Health’s Acquisition of NutraQ 2 AS
Accura advised Orkla and Orkla Health in connection with the transaction. Roschier represents Orkla. Stock exchange-listed Orkla has acquired the company NutraQ 2 AS through Orkla Health...
Pioneer Capital’s Acquisition of Din-X
Accura and Vinge advised Din-X during the entire sales process. The Scandinavian petrol company din-X has been sold to the Norwegian private equity fund Pioneer Capital....
Enemærke & Petersen’s Acquisition of Raunstrup A/S
Accura advised Enemærke & Petersen in connection with the transaction. The Danish contracting company Enemærke & Petersen, who is owned by MT Højgaard, has acquired the...
Evaxion Biotech A/S’ $30 Million Initial Public Offering
Accura was local counsel for Oppenheimer & Co. who was lead underwriter in connection with the ADS listing. Mazanti advised Evaxion Biotech. The Danish biotech company...